Table 1

Clinical characteristics and plasma lipids of women with benign breast disease and women with breast cancer and men with benign prostate hyperplasia and men with prostate cancer

Benign breast diseaseBreast cancerBenign prostate hyperplasiaProstate cancer
Number299211201130
Age (y)43.3  (41.9, 44.7)55.2  (53.4, 57.0)69.7  (68.6, 70.7)68.8  (67.2, 70.2)
BMI (kg/m2)25.2 (24.3, 26.3)25.9 (24.3, 26.3)26.5 (25.9, 26.9)26.4 (25.8, 27.1)
Plasma cholesterol (mmol/l)5.2 (5.1, 5.38)5.1 (5.0, 5.3)4.9 (4.8, 5.0)5.4 (5.2, 5.6)1-150
LDL cholesterol (mmol/l)2.8 (2.7, 2.9)2.7 (2.6, 2.9)3.0 (2.9, 3.1)3.3 (3.1, 3.5)1-151
HDL cholesterol (mmol/l)1.6 (1.5, 1.7)1.6 (1.5, 1.7)1.2 (1.2, 1.3)1.5 (1.3, 1.5)1-150
Triglycerides (mmol/l)1.2 (1.2, 1.3)1.2 (1.1, 1.3)1.4 (1.3, 1.5)1.5 (1.4, 1.6)

  • The values are presented as means (95% confidence intervals). Logarithmic transformation was done for the analyses of total triglycerides.

  • ↵1-150 p<0.0001 for the difference compared with benign prostate hyperplasia.

  • ↵1-151 p<0.007 for the difference compared with benign prostate hyperplasia.